AMLX logo

Amylyx Pharmaceuticals, Inc. (AMLX) Operating Profit

Annual Operating Profit:

-$291.88M-$330.68M(-852.23%)
December 31, 2024

Summary

  • As of today, AMLX annual operating income is -$291.88 million, with the most recent change of -$330.68 million (-852.23%) on December 31, 2024.
  • During the last 3 years, AMLX annual operating profit has fallen by -$209.19 million (-252.99%).
  • AMLX annual operating profit is now -852.23% below its all-time high of $38.80 million, reached on December 31, 2023.

Performance

AMLX Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAMLXincome statement metrics

Quarterly Operating Profit:

-$36.03M+$6.83M(+15.94%)
September 30, 2025

Summary

  • As of today, AMLX quarterly operating income is -$36.03 million, with the most recent change of +$6.83 million (+15.94%) on September 30, 2025.
  • Over the past year, AMLX quarterly operating profit has increased by +$3.43 million (+8.70%).
  • AMLX quarterly operating profit is now -278.34% below its all-time high of $20.20 million, reached on June 30, 2023.

Performance

AMLX Quarterly Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAMLXincome statement metrics

TTM Operating Profit:

-$157.34M+$3.43M(+2.13%)
September 30, 2025

Summary

  • As of today, AMLX TTM operating income is -$157.34 million, with the most recent change of +$3.43 million (+2.13%) on September 30, 2025.
  • Over the past year, AMLX TTM operating profit has increased by +$55.75 million (+26.16%).
  • AMLX TTM operating profit is now -505.50% below its all-time high of $38.80 million, reached on December 31, 2023.

Performance

AMLX TTM Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAMLXincome statement metrics

Operating Profit Formula

Operating Profit = Gross Profit − Operating Expenses

AMLX Operating Profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-852.2%+8.7%+26.2%
3Y3 Years-253.0%+34.1%+15.0%
5Y5 Years-2053.5%-319.3%-1731.3%

AMLX Operating Profit Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-852.2%at low-278.3%+70.5%-505.5%+38.5%
5Y5-Year-852.2%at low-278.3%+70.5%-505.5%+38.5%
All-TimeAll-Time-852.2%at low-278.3%+70.5%-505.5%+38.5%

AMLX Operating Profit History

DateAnnualQuarterlyTTM
Sep 2025
-
-$36.03M(+15.9%)
-$157.34M(+2.1%)
Jun 2025
-
-$42.86M(-13.4%)
-$160.77M(+6.2%)
Mar 2025
-
-$37.80M(+7.0%)
-$171.35M(+33.0%)
Dec 2024
-$291.88M(-852.2%)
-$40.65M(-3.0%)
-$255.68M(-20.0%)
Sep 2024
-
-$39.46M(+26.2%)
-$213.09M(-37.6%)
Jun 2024
-
-$53.44M(+56.2%)
-$154.91M(-90.6%)
Mar 2024
-
-$122.13M(-6414.9%)
-$81.28M(-309.5%)
Dec 2023
$38.80M
$1.93M(-89.7%)
$38.80M(+602.3%)
Sep 2023
-
$18.72M(-7.3%)
-$7.72M(+90.5%)
Jun 2023
-
$20.20M(+1084.0%)
-$81.13M(+47.9%)
DateAnnualQuarterlyTTM
Mar 2023
-
-$2.05M(+95.4%)
-$155.58M(+22.7%)
Dec 2022
-$201.34M(-143.5%)
-$44.59M(+18.4%)
-$201.34M(-8.8%)
Sep 2022
-
-$54.68M(-0.8%)
-$185.06M(-41.9%)
Jun 2022
-
-$54.25M(-13.5%)
-$130.38M(-37.7%)
Mar 2022
-
-$47.81M(-68.9%)
-$94.72M(-58.5%)
Dec 2021
-$82.69M(-112.0%)
-$28.32M(-52.3%)
-$59.77M(-49.2%)
Jun 2021
-
-$18.59M(-44.4%)
-$40.05M(-86.6%)
Mar 2021
-
-$12.87M(-49.8%)
-$21.46M(-149.8%)
Dec 2020
-$39.01M(-187.8%)
-$8.59M
-$8.59M
Dec 2019
-$13.55M
-
-

FAQ

  • What is Amylyx Pharmaceuticals, Inc. annual operating income?
  • What is the all-time high annual operating profit for Amylyx Pharmaceuticals, Inc.?
  • What is Amylyx Pharmaceuticals, Inc. annual operating profit year-on-year change?
  • What is Amylyx Pharmaceuticals, Inc. quarterly operating income?
  • What is the all-time high quarterly operating profit for Amylyx Pharmaceuticals, Inc.?
  • What is Amylyx Pharmaceuticals, Inc. quarterly operating profit year-on-year change?
  • What is Amylyx Pharmaceuticals, Inc. TTM operating income?
  • What is the all-time high TTM operating profit for Amylyx Pharmaceuticals, Inc.?
  • What is Amylyx Pharmaceuticals, Inc. TTM operating profit year-on-year change?

What is Amylyx Pharmaceuticals, Inc. annual operating income?

The current annual operating profit of AMLX is -$291.88M

What is the all-time high annual operating profit for Amylyx Pharmaceuticals, Inc.?

Amylyx Pharmaceuticals, Inc. all-time high annual operating income is $38.80M

What is Amylyx Pharmaceuticals, Inc. annual operating profit year-on-year change?

Over the past year, AMLX annual operating income has changed by -$330.68M (-852.23%)

What is Amylyx Pharmaceuticals, Inc. quarterly operating income?

The current quarterly operating profit of AMLX is -$36.03M

What is the all-time high quarterly operating profit for Amylyx Pharmaceuticals, Inc.?

Amylyx Pharmaceuticals, Inc. all-time high quarterly operating income is $20.20M

What is Amylyx Pharmaceuticals, Inc. quarterly operating profit year-on-year change?

Over the past year, AMLX quarterly operating income has changed by +$3.43M (+8.70%)

What is Amylyx Pharmaceuticals, Inc. TTM operating income?

The current TTM operating profit of AMLX is -$157.34M

What is the all-time high TTM operating profit for Amylyx Pharmaceuticals, Inc.?

Amylyx Pharmaceuticals, Inc. all-time high TTM operating income is $38.80M

What is Amylyx Pharmaceuticals, Inc. TTM operating profit year-on-year change?

Over the past year, AMLX TTM operating income has changed by +$55.75M (+26.16%)
On this page